INTRODUCTION AND OBJECTIVES: An innovative electrohydraulic discharge device has been developed to fracture kidney stones. This device is composed of an array of 18 sparker units, each generating an acoustic pulse, which coalesce to produce a single shock wave front. We report on preliminary tests to determine if the sparker array can fracture stones (in vitro) and if sparker array treatment produces a renal hemorrhagic lesion in our pig model of lithotripsy injury (in vivo).
METHODS: U-30 model stones were placed at the focus of the sparker array in a holder with 2-mm mesh openings. 600 shock waves (SWs) were then administered to each stone using a charging voltage of 21.6 kV at 60 SWs/min. All large stone fragments (! 2-mm) retained in the holder were collected, dried and weighed to determine percent of stone breakage. The renal lesion analysis portion of the study consisted of treating the left kidney of anesthetized female pigs (35-40 kg) with 2400 SWs using 21.6 kV at 60 SWs/min. Immediately after sparker array treatment the kidneys were perfusion fixed with glutaraldehyde, excised and processed to quantitate the parenchymal hemorrhagic lesion of that kidney.
RESULTS: On average, 71.3AE1.9% (meanAES.E., n¼6) of each model stone was fractured to < 2-mm in size. Renal injury analysis revealed that none of the kidneys treated with 2400 SWs (n¼3) showed evidence of hemorrhagic injury.
CONCLUSIONS: The sparker array consistently comminuted model stones demonstrating its ability to fracture stones similar to other lithotripters. However, unlike most other lithotripters, the sparker array did not cause renal injury at the settings used in this study. These findings suggest further research is warranted to determine the potential of this device.
Source of Funding: NIH grants PO1 DK-43881, and R44 DK-089703
MP62-11 EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY (ESWL) FOR RENAL STONES IS ASSOCIATED WITH DECREASED KIDNEY FUNCTION AFTER LONG TERM FOLLOW-UP
Christian Fankhauser*, Josias Grogg, Alexander Holenstein, Qing Zhong, Johann Steurer, Thomas Hermanns, Tullio Sulser, C edric Poyet, Zurich, Switzerland INTRODUCTION AND OBJECTIVES: Beside well characterized short term adverse effects of extracorporeal shock wave lithotripsy (ESWL) for the treatment of renal stones, concerns regarding long term adverse effects to the kidneys or adjacent organs (e.g. pancreas) were raised. We aimed to analyze whether ESWL applied to the kidneys is associated with decreased kidney function, hypertension or diabetes during long term follow-up.
METHODS: All patients with urolithiasis treated by ESWL at our tertiary care center between 1992 and 2013 were retrospectively identified. Cases consisted of patients treated by ESWL because of kidney stones (kidney group). Patients with distal ureter stones treated by ESWL served as a control group. Patients treated by ESWL for upper or middle ureter stones or patients treated for both, kidney and distal ureter stones were excluded. In 2016, a questionnaire was sent to all patients to assess the prevalence of decreased kidney function, hypertension and diabetes. The Swiss Health Survey data set (n¼21,597) providing population data for hypertension and diabetes but not decreased kidney function was used as an additional comparison group.
RESULTS: Of 7108 identified patients, 2,776 (39%) met the inclusion criteria. Follow-up questionnaires were returned by 764 (28%) patients of which 585 (77%) questionnaires belonged to the kidney group, and 179 (23%) to the distal ureter group. Median time between first ESWL and returned questionnaire was 12 years (8-18 years) for the kidney group and 16 years (IQR 11-20 years) for the control group. There was no significant difference between the kidney group and the control group regarding age (mean 62+-14 vs. 64+-14, p¼0.252), gender (female 34% vs. 28%, p¼0.123) and BMI (mean 26+-4 vs. 26+-4, p¼0.687). However, in the kidney group more number of ESWL sessions were observed compared to the control group (1 [IQR 1-2] vs. 1 [IQR 1-1], p<0.001). Furthermore the prevalence of decreased kidney function in the kidney group was significantly higher compared to the control group (8.3% vs. 2.9%, p¼0.015). The kidney group, control group and general population showed significant differences regarding prevalence of hypertension (47.5% vs. 49.4% vs. 27.5%, p<0.001) and diabetes (14.1% vs. 11.9% vs. 4.9%, p<0.001). In multivariable regression analyses controlling for age, gender and BMI, number of applied ESWL sessions to the kidneys was an independent predictor for decreased kidney function (OR 1.28, 95% CI 1.010 to 1.623, p¼0.041) but not for hypertension or diabetes.
CONCLUSIONS: ESWL for renal stones may lead to decreased kidney function during long term follow-up. The association between increasing number of applied ESWL sessions and decreased kidney function at long-term follow-up supports a causal relationship. , which is attributed to more widely available equipment and expertise as well as higher stone-free rates. We compared the sociodemographics of patients who underwent URS vs SWL to evaluate for URS utilization trends based on age, gender, race and location.
Source of
METHODS: The State Ambulatory Surgery and Service Database (SASD) for the state of Wisconsin for the years 2012 and 2013 was accessed which contains information regarding outpatient encounters and was queried for Current Procedural Terminology (CPT) codes pertaining to URS and SWL. We evaluated the data for usage of URS and SWL based on age, gender, race and Rural Urban Commuting Area (RUCA) code (indicating population of patient residence location). Univariate and Chi-Square analyses was used to compare the rate of URS vs SWL encounters based on gender, age, race, and location.
RESULTS: A total of 16,587 encounters were identified for URS and SWL. 10,077 (62%) encounters contained a CPT code for URS vs 6,207 (38%) for SWL. URS utilization varied based on age, specifically pediatric patients were more likely to undergo URS vs SWL when compared to adults (73% vs 62%, OR 1.8 (1.23 -2.64), p ¼ 0.002). Adults 80 years old and older were also more likely to undergo URS compared to other adult ages (73.4% vs 61%, OR 1.75 (1.49 -2.06), p < 0.001). We found no difference in the rates of URS encounters according to gender (p ¼ 0.863). Caucasian patients were more likely to have URS vs Black patients (OR 1.58, 1.32 -1.88, p < 0.001). Hispanic patients were more likely to undergo URS compared to Caucasian patients (OR 1.32, 0.61 -0.928, p ¼ 0.008). Patients living in a large town (10,000 -50,000 people) were more likely to have URS compared to those living in a metropolitan area (>50,000 people) (66% vs 61%, OR 1.25, CI 1.13 -1.38, p < 0.001) or a rural area (<2,500 people) (66% vs 60%, OR 1.30, CI 1.14 -1.50, p < 0.001).
CONCLUSIONS: URS encounters are more common than SWL (62% vs 38%). Pediatric patients and those 80 years old and older Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e831
